Related Experiment Video
Updated: Jun 8, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
The Sardinian way to type 1 diabetes
1Centre of Diabetes and Metabolic Disease, Department of Internal Medicine, San Michele Hospital, Cagliari, Sardinia, Italy. marcosongini@aob.it
Journal of Diabetes Science and Technology
|October 6, 2010
Summary
Sardinia has a high incidence of type 1 diabetes mellitus (T1DM). Researchers launched a project to study T1DM
Area of Science:
- Epidemiology
- Immunology
- Genetics
Background:
- Sardinia and Finland exhibit the highest global rates of type 1 diabetes mellitus (T1DM).
- The island's unique genetic and epidemiological profile makes it an ideal location for T1DM research.
- Investigating environmental, immunological, and genetic factors is crucial for understanding T1DM's origins.
Purpose of the Study:
- To map the geographical distribution of T1DM in Sardinia.
- To investigate preclinical T1DM phases in genetically susceptible individuals.
- To develop predictive models and preventive strategies for high-risk populations.
Main Methods:
- The Insulin-Dependent Diabetes Mellitus Sardinia Project initiated in 1990.
- Geographical mapping of T1DM cases across the island.
- Longitudinal study of a large cohort at genetic risk for T1DM.
Main Results:
- The project established a comprehensive dataset on T1DM distribution and risk factors in Sardinia.
- Early identification of individuals in preclinical stages of T1DM was achieved.
- Data collection facilitated the understanding of T1DM's multifactorial etiology.
Conclusions:
- Sardinia serves as a key research area for type 1 diabetes mellitus.
- Understanding preclinical phases is vital for effective T1DM prevention.
- Developing predictive models can guide public health interventions for T1DM.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...